↓ Skip to main content

Cochrane Database of Systematic Reviews

Pregabalin monotherapy for epilepsy

Overview of attention for article published in Cochrane database of systematic reviews, October 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter
7 tweeters
wikipedia
4 Wikipedia pages
f1000
1 research highlight platform

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
125 Mendeley
Title
Pregabalin monotherapy for epilepsy
Published in
Cochrane database of systematic reviews, October 2012
DOI 10.1002/14651858.cd009429.pub2
Pubmed ID
Authors

Qin Zhou, Jinou Zheng, Lu Yu, Xiaoyan Jia

Abstract

Many people with epilepsy suffer from poorly controlled seizures, despite current antiepileptic treatments. Due to high rates of treatment resistance, there is interest in new pharmacological treatment options such as pregabalin. However, it remains unclear whether existing evidence of pregabalin is rigorous enough to support its monotherapy.

Twitter Demographics

The data shown below were collected from the profiles of 7 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 125 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
United States 1 <1%
South Africa 1 <1%
Unknown 122 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 17 14%
Student > Master 16 13%
Student > Bachelor 14 11%
Student > Ph. D. Student 11 9%
Student > Postgraduate 10 8%
Other 25 20%
Unknown 32 26%
Readers by discipline Count As %
Medicine and Dentistry 45 36%
Nursing and Health Professions 13 10%
Psychology 9 7%
Pharmacology, Toxicology and Pharmaceutical Science 7 6%
Biochemistry, Genetics and Molecular Biology 4 3%
Other 14 11%
Unknown 33 26%

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 January 2023.
All research outputs
#3,685,025
of 23,033,713 outputs
Outputs from Cochrane database of systematic reviews
#6,204
of 12,353 outputs
Outputs of similar age
#26,982
of 176,224 outputs
Outputs of similar age from Cochrane database of systematic reviews
#109
of 234 outputs
Altmetric has tracked 23,033,713 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,353 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 31.5. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 176,224 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 234 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.